Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis

NCT03886350 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT03886350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03886350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis
Lead sponsor
University Hospital, Tours
Phase
Observational
Overall status
Completed
Start date
April 3, 2019
Completion date
July 20, 2020
Enrollment
62 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, inflammatory response, innate immunity